Journal of Shanghai Jiao Tong University (Medical Science) >

2023 , Vol. 43 >Issue 5: 571 - 579

DOI: https://doi.org/10.3969/j.issn.1674-8115.2023.05.007

Basic research

Effect of lysine demethylase 5C on renal carcinoma metastasis

  • Ningdai CHEN ,
  • Bingqian ZHOU ,
  • Zheyi CHEN ,
  • Shiyu CHEN ,
  • Yingxia ZHEN
Expand
  • Department of Laboratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200082, China

Received date: 2023-01-07

  Accepted date: 2023-03-31

  Online published: 2023-07-11

Supported by

National Natural Science Foundation of China(82071753);Shanghai Municipal Health Commission Fund Support(20224Z0025)

Fold

Abstract

Objective ·To investigate the effects of lysine demethylase 5C (KDM5C) on the migration and invasion of renal clear cell carcinoma, analyze the genes regulated by KDM5C and explore the mechanisms of promoting renal cell carcinoma after its inactivation. Methods ·Lentivirus was used to construct human renal clear cell carcinoma 786-O and Caki-1 cell lines with KDM5C stable knockout. The changes of migration and invasion abilities of renal carcinoma cells were observed by Transwell assay. Epithelial-mesenchymal transition (EMT) protein expression was detected by Western blotting. Differential gene analysis and functional pathway enrichment analysis were performed by using 786-O Control-sg, KDM5C-sg 2 group cell RNA sequencing data and The Cancer Genome Atlas (TCGA) public database to further explore the cancer-promoting mechanisms after KDM5C deletion. The up-regulated EMT-related genes in sequencing data were screened out according to the EMT gene set, and the genes were screened by survival analysis and univariate COX analysis. Finally, LASSO regression analysis and risk forest model were used to further screen genes highly related to the phenotype after KDM5C knockout. Results ·After the deletion of KDM5C, both 786-O and Caki-1 cells showed significant migration and invasion phenotypes compared with control groups. Analysis of TCGA database indicated that mutation of KDM5C in renal cancer patients led to poor prognosis (P=0.042). RNA sequencing analysis showed that KDM5C knockout may affect cell adhesion molecules and upregulate epithelial-mesenchymal transition-related genes. Western blotting detected the increased expression levels of β-catenin, Vimentin and Snail proteins in two kinds of cells after KDM5C knockout. Finally, ten up-regulated EMT genes were obtained by survival analysis and univariate COX analysis for LASSO regression analysis and risk forest model prediction. The results showed that KDM5C may have a regulatory effect on PLAUR gene. Conclusion ·The mutation of KDM5C can promote the development of renal carcinoma by enhancing migration and invasion.

Key words： lysine demethylase 5C (KDM5C); renal clear cell carcinoma; migration; epithelial-mesenchymal transition

Cite this article

Ningdai CHEN , Bingqian ZHOU , Zheyi CHEN , Shiyu CHEN , Yingxia ZHEN . Effect of lysine demethylase 5C on renal carcinoma metastasis[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(5) : 571 -579 . DOI: 10.3969/j.issn.1674-8115.2023.05.007

References

1 LOPEZ-BELTRAN A, SCARPELLI M, MONTIRONI R, et al. 2004 WHO classification of the renal tumors of the adults[J]. Eur Urol, 2006, 49(5): 798-805.
2 SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2016[J]. CA, 2016, 66(1): 7-30.
3 HSIEH J J, PURDUE M P, SIGNORETTI S, et al. Renal cell carcinoma[J]. Nat Rev Dis Primers, 2017, 3: 17009.
4 DALGLIESH G L, FURGE K, GREENMAN C, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes[J]. Nature, 2010, 463(7279): 360-363.
5 TAHILIANI M, MEI P C, FANG R, et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation[J]. Nature, 2007, 447(7144): 601-605.
6 HONG Z, WU G, XIANG Z D, et al. KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN[J]. Biomedecine Pharmacother, 2019, 114: 108793.
7 LIN H S, YANG G W, YU J, et al. KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1[J]. Biomedecine Pharmacother, 2018, 107: 1205-1209.
8 ZHENG Q, LI P F, ZHOU X, et al. Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis[J]. Theranostics, 2021, 11(18): 8674-8691.
9 XU L M, WU W, CHENG G L, et al. Enhancement of proliferation and invasion of gastric cancer cell by KDM5C via decrease in p53 expression[J]. Technol Cancer Res Treat, 2017, 16(2): 141-149.
10 RONDINELLI B, ROSANO D, ANTONINI E, et al. Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer[J]. J Clin Invest, 2016, 126(11): 4387.
11 ZHANG B, ZHOU B H, XIAO M, et al. KDM5C represses FASN-mediated lipid metabolism to exert tumor suppressor activity in intrahepatic cholangiocarcinoma[J]. Front Oncol, 2020, 10: 1025.
12 JOHN R M, ROUGEULLE C. Developmental epigenetics: phenotype and the flexible epigenome[J]. Front Cell Dev Biol, 2018, 6: 130.
13 YOUNG A P, SCHLISIO S, MINAMISHIMA Y A, et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400[J]. Nat Cell Biol, 2008, 10(3): 361-369.
14 MANDRIOTA S J, TURNER K J, DAVIES D R, et al. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron[J]. Cancer Cell, 2002, 1(5): 459-468.
15 IBRAGIMOVA I, MARADEO M E, DULAIMI E, et al. Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC[J]. Epigenetics, 2013, 8(5): 486-493.
16 DE CUBAS A A, RATHMELL W K. Epigenetic modifiers: activities in renal cell carcinoma[J]. Nat Rev Urol, 2018, 15(10): 599-614.
17 ZHANG T, WANG B F, SU F, et al. TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR[J]. Int J Biol Sci, 2022, 18(11): 4560-4577.
18 HUANG C, XIE D C, CUI J J, et al. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system[J]. Clin Cancer Res, 2014, 20(6): 1477-1488.
19 NISHI H, SASAKI T, NAGAMITSU Y, et al. Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells[J]. Oncol Rep, 2016, 35(2): 992-998.
Options
Outlines

/

〈 〉